section 8
on 24 Mar 2023
Last Applicant/ Owned by
82152
Planegg/Martinsried
DE
Serial Number
86605899 filed on 22nd Apr 2015
Registration Number
5038910 registered on 13th Sep 2016
Correspondent Address
Leonard P. Linardakis
Filing Basis
No Filing Basis
Disclaimer
"IMMUNOTHERAPIES"
Medicines for humans and animals for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, medicated serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodeRead More
Medicines for humans and animals for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, medicated serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays for testing of bodily fluids for use in disease detection, namely, tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, all prepared by means of molecular biology, genetic engineering or biotechnological methods; substances for medical diagnosis purposes, namely, proteins, nucleic acids, cell products, protein conjugates, peptides, enzymes and enzyme preparations, particularly antibodies and T cell proteins; T cells, dendritic cells, and other cells of the immune system, viruses, and virus-like particles, all for medical purposes; liposomes for medical purposes; plant extracts for medical purposes; low molecular active ingredients, namely, medicines for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, adjuvants, serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays that test for the presence of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, autoimmune diseases and immune therapy
Services of a molecular biology or biotechnology laboratory, particularly research and development work in the field of human medical and veterinary medical diagnosis and therapy by means of molecular biology, genetic engineering or biotechnological methods as well as in the field of screening for pharmaceutically active compounds; design and development of test methods and test kits in the field of biotechnology and medicine
Medical analyses and medical consultancy in the context of the treatment of single persons, particularly in the field of tumor precursors, benign and malignant tumor diseases, autoimmune diseases and immunotherapy
Licensing of intellectual property, including trademarks and patents in the field of biotechnology, pharmacy, and medicine
No 86605899
No Service Mark
No ZIMM_TM001
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 24th Mar 2023 | CANCELLED SEC. 8 (6-YR) |
| 13th Sep 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 13th Sep 2016 | REGISTERED-PRINCIPAL REGISTER |
| 28th Jun 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 28th Jun 2016 | PUBLISHED FOR OPPOSITION |
| 08th Jun 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 23rd May 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 13th May 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 12th May 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 12th May 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
